Among the most challenging aspects of adoptive cell therapies and CAR-T engineering are the identification and use of antigens for focused immune effector cell activation to cancer targets only
Among the most challenging aspects of adoptive cell therapies and CAR-T engineering are the identification and use of antigens for…